Ashley Cain has shared another update with fans amid his baby daughter Azaylia’s ongoing fight with leukaemia, revealing that an essential drug she needs is ‘not being released’.
The reality star, 30, took to his Instagram story overnight to thank fans for helping raise £1.45million to help Azaylia’s fight, but admitted there were still obstacles in the way.
He told his followers: ‘I honestly can’t thank everyone enough, I’m looking really tired and I’ve got pain in my eyes as we found out today that one of the drugs that Azaylia needs to start treatment with tomorrow in order to bring her leukaemia count down and get her into remission is not being released by the pharmaceutical companies.
‘So not only today have I been looking after Azaylia, but going through heavy talks with consultants, doctors and pharmaceutical companies to try and get this essential drug that Azaylia needs.’
Ashley did not specify which drug it was that hadn’t been released, as he revealed that Azaylia had also pulled out her NG tube which goes from her nose to her stomach and had to have it re-fitted.
He has been raising money for the treatment his daughter needs in Singapore in the hopes of saving her life after she relapsed following an unsuccessful bone marrow transplant.
Ashley’s daughter Azaylia is battling leukaemia (Picture: Ashley Cain/Instagram)
The family are hoping to secure a place in Singapore for Azaylia to have year-long CAR-T therapy and a haplo transplant which could potentially save her life.
A deposit of £500,000 is needed just to be accepted into the hospital and onto the programme, and with the fundraiser having now topped £1.45million, the family are hopeful they will be able to get the wheels in motion.
Azaylia’s story touched Ashley’s fans and friends’ hearts meaning his target of £1million was quickly surpassed.
As well as his followers, many of Ashley’s celebrity friends have donated towards Azaylia’s fight, including Molly-Mae Hague, Maura Higgins and Mrs Hinch, and PrettyLittleThing founder Umar Kamani added £20,000 to the fund.
Credit: Original article published here.